Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
May
9
2016
Supplemental Nutrition Assistance Program (SNAP): Retailers’ Perspective Examined at House Agriculture Committee Hearing Squire Patton Boggs (US) LLP
May
9
2016
Oh, Canada (An FSVP Update): Foreign Supplier Verification Program Keller and Heckman LLP
May
9
2016
New USPTO Guidance On Patent Eligibility Of Diagnostic Methods Foley & Lardner LLP
May
7
2016
FDA Extends Regulatory Authority Over All Tobacco Products, Including E-Cigarettes, Cigars and Hookahs Armstrong Teasdale
May
6
2016
FDA Announces Availability of Final Guidance on Menu Labeling McDermott Will & Emery
May
6
2016
Tobacco Turmoil and the FDA's Regulatory Authority Keller and Heckman LLP
May
6
2016
Catfish Crossover Complete Keller and Heckman LLP
May
5
2016
NYC Extends Tax Credit Available to Biotech Companies Mintz
May
5
2016
FDA Issues Deeming Rule regarding Tobacco Products Michael Best & Friedrich LLP
May
5
2016
EPA Issues Pesticide Tolerance Crop Grouping Program Amendment IV Bergeson & Campbell, P.C.
May
5
2016
Are Drug Prices Really Too High? Foley & Lardner LLP
May
5
2016
FDA Issues Menu Labeling Final Guidance Morgan, Lewis & Bockius LLP
May
4
2016
NNCO Accepting Registrations for SME and NanoEHS Webinars Bergeson & Campbell, P.C.
May
4
2016
Viva Vaping: Food Law Keller and Heckman LLP
May
4
2016
District Court Applies Mayo To Treatment Claims But Denies Motion To Dismiss BMS Keytruda Litigation Foley & Lardner LLP
May
4
2016
NGOs Call for Actions, Not Words, from the European Commission on Nanotechnology Bergeson & Campbell, P.C.
May
3
2016
Bio-rad Laboratories v. California Institute of Tech: Final Written Decision Finding No Inconsistency between Expert Testimony and Earlier Paper by Same Expert IPR2015-00009 Faegre Drinker
May
3
2016
Citizen Petition Requests FDA Ban Certain Phthalates; Revoke Clearances for Others Keller and Heckman LLP
May
3
2016
Senator Markey Criticizes FDA’s GRAS Review System Keller and Heckman LLP
May
3
2016
New Compounding Policies from FDA May Affect Hospital and Health System Pharmacy Operations Mintz
May
3
2016
Pets and Vets: Therapeutic Vet Diet Compliance Policy Guide Finalized Keller and Heckman LLP
May
2
2016
FTC Trims Fat Off Even More Companies Selling Weight Loss Products Proskauer Rose LLP
Apr
29
2016
Korea to Require Registration of Foreign Food and Food Packaging Facilities Keller and Heckman LLP
Apr
29
2016
New Board of Pharmacy Regulations Significantly Narrow the Sole Proprietor Exemption and Impose New Compounding Standards Dinsmore & Shohl LLP
Apr
29
2016
"Generally Recognized as Safe" Under Fire Keller and Heckman LLP
Apr
29
2016
Cole-Bishop Amendment to Agricultural Appropriations Bill Amending Grandfather Date for "Deemed" Tobacco Products Passes House Committee - What Next? Keller and Heckman LLP
Apr
29
2016
Pharmaceutical Giant Pfizer To Pay $785 Million In Settlement Of Qui Tam Lawsuit Alleging Subsidiary Wyeth Engaged in Fraudulent Drug Rebate Scheme Tycko & Zavareei LLP
Apr
29
2016
Follow the Data: FDA Addresses cGMPs for Data Integrity Issues in Draft Guidance Morgan, Lewis & Bockius LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins